Hims Hers Really Growth Stock Faces Reality Check Now
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Knowing when to update your personal budget is crucial for staying aligned with your financial goals. Explore the signs that indicate it's time for a revision.
19,364 articlesHims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
DC Blockchain Summit presses ahead in Washington as Dubai's Token2049 is delayed amid geopolitical risk, highlighting...
Bitcoin faces a pivotal test as Moody’s recession odds rise toward a historic point. Macro signals suggest crypto cou...
Analysts push a higher target for NVIDIA as demand for Blackwell and Vera Rubin accelerates. The latest guidance sign...
SanDisk moved down about 5% after reporting strong Q4 results, fueling a sharp debate on whether the AI-led rally in ...
Bank of America reinstates Buy on Microsoft, guiding toward a $500 price target as Azure growth and Copilot adoption ...
A California jury has ruled that Meta and YouTube were liable for harms linked to minors on their platforms, awarding...
Red Cat Holdings posted a record Q4 revenue of $26.2 million and full-year $40.7 million, but margins stayed thin and...
Core Scientific reports higher first-quarter revenue and gross profit, yet a net loss due to impairment charges derai...
Stocks all-time highs still attract buyers as earnings momentum and AI-driven demand support another leg up. Here's t...
Onsemi posted weaker Q1 2026 results amid a slowing silicon carbide market and rising competition from Sony in image ...
Three under-$10 energy names are drawing attention as one yields 8.8%, another is up 83% in a year, and market chatte...